Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects

相似書籍

• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
  由: Sakurai, Yuuichi, et al.
  出版: (2015)
• Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
  由: Ashida, K., et al.
  出版: (2015)
• Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
  由: Ashida, K., et al.
  出版: (2015)
• The binding selectivity of vonoprazan (TAK-438) to the gastric H(+),K(+)−ATPase
  由: Scott, David R., et al.
  出版: (2015)
• Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised controlled trials
  由: Miwa, H., et al.
  出版: (2016)